| Also known as |
Glibenclamide |
| Blood pressure |
Can potentially lower blood pressure |
| Chemical name |
1-[4-[2-(5-Chloro-2-methoxybenzamido)ethyl]phenylsulfonyl]-3-cyclohexylurea |
| Dosage (medical) |
Typically, 1.25 to 20 mg per day in divided doses |
| Dosage (sports) |
Not applicable |
| Effects |
Lowers blood glucose by stimulating insulin release from pancreatic beta cells |
| Formula |
C23H28ClN3O5S |
| Half-life |
10 hours |
| Hepatotoxicity |
Rare, but can occur |
| Lab Test |
Blood glucose levels, HbA1c |
| Main action |
Antidiabetic agent |
| Side effects |
Hypoglycemia, nausea, heartburn, weight gain, allergic skin reactions |
| Storage conditions |
Store at room temperature, away from moisture and heat |
| Strength |
10 mg |
| Substance class |
Sulfonylurea |
| Trade name |
Diabeta, Micronase, Glynase |
| Use in sports |
Not typically used in sports |
| Water Retention |
Minimal |
| Manufacturer |
USV Private Ltd. |
